Risako Miura

Dr. Risako Miura

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
KSKoichi Sasaki
Koichi Sasaki
JIJun Ishihara
Jun Ishihara
AIAko Ishihara
Ako Ishihara
RMRisako Miura
Risako Miura
AMAslan Mansurov
Aslan Mansurov
JHJeffrey A. Hubbell
Jeffrey A. Hubbell
Collagen-binding ability improves serum albumin as an anti-cancer drug carrier, resulting in enhanced therapeutic efficacy.

4 December 2019 in Biomacromolecules
Verified
Journal Article
Closed access
RMRisako Miura
Risako Miura
SSShin-Ichi Sawada
Shin-Ichi Sawada
SMSada-Atsu Mukai
Sada-Atsu Mukai
YSYoshihiro Sasaki
Yoshihiro Sasaki
KAKazunari Akiyoshi
Kazunari Akiyoshi

Verified
Journal Article
Open access
PDF file
RKRiku Kawasaki
Riku Kawasaki
KKKosuke Kondo
Kosuke Kondo
RMRisako Miura
Risako Miura
KYKeita Yamana
Keita Yamana
HIHinata Isozaki
Hinata Isozaki
AIAtsushi Ikeda
Atsushi Ikeda
Developing photoactivatable theranostic platforms with integrated functionalities of biocompatibility, targeting, imaging contrast, and therapy is a promising approach for cancer diagnosis and therapy. Here, we report a theranostic agent based on a hybrid nanoparticle comprising fullerene nanocrystals and gold nanoparticles (FGNPs) for photoacoustic imaging and photothermal therapy. Compared to gold nanoparticles and fullerene crystals, FGNPs exhibited stronger photoacoustic signals and photothermal heating characteristics by irradiating light with an optimal wavelength. Our studies demonstrated that FGNPs could kill cancer cells due to their photothermal heating characteristics in vitro. Moreover, FGNPs that are accumulated in tumor tissue via the enhanced permeation and retention effect can visualize tumor tissue due to their photoacoustic signal in tumor xenograft model mice. The theranostic agent with FGNPs shows promise for cancer therapy.

7 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RMRisako Miura
Risako Miura
YTYoshiro Tahara
Yoshiro Tahara
SSShin-Ichi Sawada
Shin-Ichi Sawada
YSYoshihiro Sasaki
Yoshihiro Sasaki
KAKazunari Akiyoshi
Kazunari Akiyoshi
The success of immunotherapeutic vaccines is often limited by their inability to activate the cytotoxic T lymphocyte (CTL)-inducing Th1 pathway. We investigated the ability of self-assembled nanogels (CHP or CH-CDex) to activate this pathway, and characterised them chemically and biologically. Once loaded with antigen (ovalbumin, OVA) their OVA encapsulation and dissociation rates suggested the possibility of effective antigen delivery. The DC2.4 dendritic cell line took up either vaccine time-dependently, but both vaccines required CpG DNA for class I MHC presentation. The nanogel vaccines interacted with RAW264.7, a Balb/c mouse-derived macrophage cell line, and co-localised with lysosomes, suggesting their endocytotic internalization in RAW264.7. Both vaccines activated CTLs better than OVA alone. Unlike OVA alone, the nanogel vaccines induced IgG2a antibody production in mice, whereas the former induced IgG1 antibodies. OVA-nanogel delivery to the draining lymph nodes (DLNs) was higher than that for OVA alone, reaching a deeper medullary area. Furthermore, Langerin+CD103+DCs interacted with the nanogel vaccines effectively, which is a subset of cross-presentation DC, in the DLNs. The nanogel vaccines each had good anti-tumour efficacy in OVA tumour-bearing mice compared with the OVA alone. Thus, CHP and CH-CDex nanogels should be investigated further because of the great potential they offer for immunotherapy.

25 February 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
RMRisako Miura
Risako Miura
SSShin-Ichi Sawada
Shin-Ichi Sawada
SMSada-Atsu Mukai
Sada-Atsu Mukai
YSYoshihiro Sasaki
Yoshihiro Sasaki
KAKazunari Akiyoshi
Kazunari Akiyoshi
Combination therapy of OVA/CHP nanogel vaccine with anti-PD-1 antibody synergistically improved anti-tumor effect and survival rate without side effects.

4 July 2024 in Chemistry – An Asian Journal
Verified
Journal Article
Open access
SFSeiya Fujita
Seiya Fujita
RORiku Omokawa
Riku Omokawa
KYKeita Yamana
Keita Yamana
RKRiku Kawasaki
Riku Kawasaki
RMRisako Miura
Risako Miura
AIAtsushi Ikeda
Atsushi Ikeda
Photoacoustic (PA) imaging is a novel biological imaging technique with superior depth resolution compared to fluorescence imaging. The efficacy of PA imaging depends on contrast agents that possess considerable absorbance at longer wavelengths, coupled with high permeability in biological tissue and minimal fluorescence, achieved through mitigating aggregation‐caused quenching (ACQ) that attenuates PA intensity. Despite the successful transfer of porphyrin 2 featuring amino moieties from polysaccharides to liposomes, most of 2 incorporated within λ‐carrageenan (CGN‐2 complex) remained in CGN under acidic lysosomal conditions (pH 5.0). Consequently, the CGN‐2 complex exhibited a strong PA signal under 680 nm photoirradiation in Colon26 cells owing to the ACQ of 2. Moreover, the PA intensity of the CGN‐2 complex was further enhanced under 780 nm photoirradiation owing to the increased absorbance at 780 nm facilitated by the redshift of the Q‐band at pH 5.0.